C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof

Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
11/2006
11/30/2006	US20060269530 RNA interference compositions and methods
11/30/2006	US20060269522 Sequence of natural or synthetic retroelements enabling nucleotide sequence insertion into a eukaryotic cell
11/30/2006	CA2609276A1 Rapid production of adenovirus-free recombinant adenovirus vectors
11/30/2006	CA2608579A1 Scalable fermentation process
11/29/2006	EP1726642A1 Large-scale fermentation process for bacteriophages
11/29/2006	EP1725581A1 Novel assay for the separation and quantification of hemagglutinin antigens
11/29/2006	EP1725257A1 Chicken anemia virus vaccine from cell line
11/29/2006	EP1026246B1 Avian infectious herpesvirus recombinants and recombinant vaccines prepared with the use of the same
11/29/2006	EP0719336B1 Modified plant viruses as vectors of heterologous peptides
11/29/2006	CN1871518A Method of detecting hepatitis c virus
11/29/2006	CN1871355A Method for the recovery of non-segmented, nagative-stranded rna viruses from cdna
11/29/2006	CN1871027A 疫苗 Vaccine
11/29/2006	CN1871026A 黄病毒疫苗 Flavivirus vaccines
11/29/2006	CN1869243A Recombined porcine adenovirus based viral vaccines and vectors
11/29/2006	CN1869234A Recombination newcastle disease LaSota weak virus vaccine for expressing poultry influenza virus H5 sub type HA protein
11/29/2006	CN1869063A Preparation method of polypeptide for inhibiting gelatin enzyme A activity and its application
11/29/2006	CN1869062A Polypeptide for inhibiting gelatin enzyme A activity and its preparation method and application
11/29/2006	CN1869061A Peptidomimetic protease inhibitors
11/29/2006	CN1868545A Improved vaccines
11/29/2006	CN1286981C Combination adeno-associated virus of expression human CYP2J2 antigene and its preparation method
11/29/2006	CN1286980C Recombination adeno-associated virus of expression human antisense phospho lamban gene and its preparation method
11/29/2006	CN1286972C Method for constructing weak strain of plant virus
11/28/2006	US7141406 Using anion exchange chromatography to enrich for adenoviral nucleotide sequences
11/28/2006	US7141405 Hepatotropic flavivirus which is phylogenetic to human hepatitis C virus (GBV-B); drug screening
11/28/2006	US7141243 gM-negative EHV-mutants without heterologous elements
11/28/2006	CA2311395C Flavivirus expression and delivery system
11/23/2006	WO2006123781A1 Methods for recovering microorganism and nucleic acid using fine particle and kit to be used for the methods
11/23/2006	WO2006122964A1 Methods for the production of a whole-inactivated west nile virus vaccine
11/23/2006	WO2006122476A1 A method of inactivating virus, treatment system and device used thereof
11/23/2006	WO2006055778A3 Immunoglobulin variable region cassette exchange
11/23/2006	WO2006020480A3 Adenoviral vector compositions
11/23/2006	WO2005118825A3 Chimeric adenoviruses for use in cancer treatment
11/23/2006	US20060263883 Recombinant herpes viruses for preparing recombinant adeno-associated viruses
11/23/2006	US20060263804 Functional influenza virus-like particles (VLPs)
11/23/2006	US20060263766 Compositions and chromatography materials for bioseparation
11/22/2006	EP1724338A1 Methods for the production of a whole-inactivated West Nile Virus vaccine
11/22/2006	EP1723168A2 Beak and feather disease virus sequences, compositions and vaccines and the use thereof in therapy, diagnosis and assays
11/22/2006	EP1722814A2 Infectious bursal disease virus antigenic isolates and vaccines
11/22/2006	EP1531692B1 Virulent phages to control listeria monocytogenes in foodstuffs and in food processing plants
11/22/2006	EP1309342B1 Production of a chimeric human papillomavirus
11/22/2006	EP1214098B1 Capsid-modified recombinant adenovirus and methods of use
11/22/2006	EP1169473B1 High sensitivity phage display biomolecule detection
11/22/2006	EP1163522B1 Method for detecting msrv-1 induced superantigen activity in a biological sample
11/22/2006	EP1037603B1 Membrane virus host range mutations and their uses as vaccine substrates
11/22/2006	CN1867667A Coronavirus, nucleic acid, protein and methods for the generation of vaccine, medicaments and diagnostics
11/22/2006	CN1865449A 病毒株 Strains
11/21/2006	US7138274 Advanced oral poliovirus vaccine (Adv-OPV) deprived of the possibility of vaccine associated paralytic poliomyelities (VAPP)
11/21/2006	US7138252 For prevention/treatment of allergies/cancer/drug addiction/poisoning
11/21/2006	US7138231 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
11/21/2006	CA2076793C Methods and reagents for hepatitis c detection
11/16/2006	WO2006120503A1 Pharmaceutical composition for treating acquired immunodeficiency
11/16/2006	WO2005082020A8 Flavivirus vaccines
11/16/2006	US20060258594 Antibodies to the HIV-1 Tat protein, which bind specifically to a specific epitope found in different HIV-1 strains and subtypes; for use in passive therapy
11/16/2006	US20060258005 Novel virus vector
11/16/2006	US20060257889 Ribonuclease resistant RNA preparation and utilization
11/16/2006	US20060257856 Heterodimeric receptor libraries using phagemids
11/16/2006	US20060257852 Severe acute respiratory syndrome coronavirus
11/16/2006	US20060257425 Inactivated nodavirus vaccine
11/16/2006	US20060257424 Having mutation in viral nucleic acid encoding viral protein 2; bird and chicken vaccines
11/15/2006	EP1721985A1 Nucleic acid construct containing full-length genome of human hepatitis c virus, recombinant full-length virus genome replicative cell having the nucleic acid construct transferred thereinto and method of constructing hepatitis c viral particles
11/15/2006	EP1721981A1 Recombinant varicella-zoster virus
11/15/2006	EP1720519A1 Lyophilization method to improve excipient crystallization
11/15/2006	EP1222281B1 Immunoligically significant herpes simplex virus antigens
11/15/2006	CN1863815A Polypeptides having brain disposition activity and utilization of the same
11/15/2006	CN1284859C Membrane virus host range mutations and their uses as vaccine substrates
11/14/2006	US7135561 Infectious bovine viral diarrhea virus clone
11/14/2006	US7135282 Chimeric viral particle with exogenous peptide inserted in VP-S of cowpea mosaic virus; viral particle capable of assembly in a host cell or tissue
11/14/2006	US7135187 System for production of helper dependent adenovirus vectors based on use of endonucleases
11/09/2006	WO2006119096A2 Infectious particle composition and methods of use thereof
11/09/2006	US20060251681 Culturing a eukaryotic host cell transformed with a recombinant DNA construct including a Venezuelan equine encephalitis replicon vector, and at least one DNA fragment encoding any one of the Marburg virus proteins
11/09/2006	US20060251663 Employment of rotavirus proteins, derived proteins and peptides for the modulation of tisssue permeability
11/09/2006	US20060251623 Packaged virus-like particles
11/08/2006	EP1718738A2 Virus purification methods
11/08/2006	CN1283802C Recombinant adenovirus and its application in malignant tumor treatment
11/08/2006	CN1283801C Protein expression in baculovirus vector expression system
11/08/2006	CN1283789C Aike 30 Virus and its use
11/08/2006	CN1283788C Recombination pseudorabies virus for expressing pig breeding and respiration comproehensive oyndrome virus and application
11/08/2006	CN1283315C Bovine respiratory coronavirus as a vaccine
11/07/2006	US7132521 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
11/07/2006	US7132396 Compositions which can be used for regulating the activity of parkin
11/07/2006	US7132290 Recombinase-based system for combustion of adenovirus vectors
11/07/2006	US7132284 Adenovirus packaging cell lines
11/07/2006	US7132271 Methods for enhancing the production of viral vaccines in cell culture
11/07/2006	US7132233 using capture oligonucleotides, primers and probes derived from conserved regions of the West Nile virus genome
11/07/2006	US7132106 Plasmid capable of-directly transfecting cell and expressing nidovirales virus; gene therapy; veterinary medicine; genetic vaccines; immunotherapy
11/02/2006	WO2006115170A1 Hsv1-hf10 virus therapy for head-and-neck cancer
11/02/2006	WO2005095442A8 Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins
11/02/2006	US20060246569 Packaging systems for human recombinant adenovirus to be used in gene therapy
11/02/2006	US20060246424 Self-replicating RNA molecule from hepatitis C virus
11/02/2006	US20060246091 Avidin-pseudotyped viral vectors and their use
11/02/2006	EP1716858A2 Oncolytic virus
11/02/2006	EP1716250A2 Determination of hepatitis c virus genotype
11/02/2006	EP1716164A1 Targeted delivery of rna interference molecules for the treatment of ige-mediated disorders
11/02/2006	EP1399551B1 Method for separating bacterial cells and cell components
11/02/2006	EP1261629B1 Rotavirus pseudoviral particles and use thereof for vectorizing proteins or nucleic acids
11/02/2006	EP1144005B1 Treatment of papillomavirus infections
11/02/2006	EP1105157B1 Protein delivery system using human papillomavirus virus-like particles
11/01/2006	CN1856575A DNA transfection system for the generation of infectious influenza virus
10/2006
10/31/2006	US7129342 Infectious cDNA clone of GB virus B and uses thereof
10/31/2006	US7128915 Membrane virus host range mutations and their uses as vaccine substrates

1 ... 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 ... 267